Title
Category
Credits
Event date
Cost
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will provide participants with insight into newer approaches that effectively integrate standard interventions into management plans tailored to the individual’s particular symptoms, review the value of pulmonary rehabilitation, and outline the effective evaluation of therapeutic responses.
  • Disease management
  • Health equity
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore recent advances in the diagnosis and treatment of Pompe disease and other LSDs, including current clinical trials. It will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s) and highlight the role of the interprofessional team in evaluating and improving care for patients with these conditions.
  • Disease management
  • Health equity
  • Rare diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 ASWB - Social Workers
$0.00
In this podcast Nealie White, an individual with Pomp disease, will share her insights and perspectives, and panelists will provide strategies that the interprofessional health care team can utilize to better support people who are impacted by rare diseases.
  • Infectious diseases
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 APA - Psychologists
  • 0.50 Attendance - General Attendance
  • 0.50 ASWB - Social Workers
$0.00
This activity will provide participants with the latest science on monkeypox, describing the spectrum of associated symptoms and signs, virulence, and common routes of transmission. Discussion will also focus on the factors driving this outbreak, approaches to prevention and management, and an overview of the impact of this disease globally and in comparison with the current COVID-19 public health emergency.
  • Infectious diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 ASWB - Social Workers
$0.00
This activity will provide participants with the latest information on the status of the MP outbreak, including its origin, at-risk populations, efficacy of available vaccines, pain and symptom management, risks of delayed diagnosis and mortality. Emerging research on MP prevention and treatment interventions will also be discussed.
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Diabetes can cause potentially irreparable eye damage and poor vision over time. This activity will review the role of optometrists in the areas of prevention, co-management and rehabilitation for individuals with diabetes. It will focus on how to conduct a diabetes risk assessment, ongoing care of individuals with known diabetes and collaboration among members of the interprofessional health care team for optimal outcomes. Key strategies for vision rehabilitation will also be addressed.
  • Disease management
  • Health equity
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore the recent advances in the diagnosis and treatment of achondroplasia and other causes of disproportionate short stature. It will also share the importance of the interprofessional team to provide insights, perspectives and strategies to support the well-being of both the individual and their family/caregiver(s).
  • Palliative care and hospice
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 CDR - Dietitians
  • 1.25 ASWB - Social Workers
$0.00
Activity description To promote diversity and cultural competence in health care providers, help decrease barriers and achieve the goal of trust and successful communication in end-of-life care in interracial settings, an assessment of patients' values, beliefs and preferences are needed. This activity will identify disparities and discuss barriers preventing underrepresented diverse groups from access to hospice and end-of-life care and explore ways to provide equitable care to all diverse groups at the end of life.
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Age-related macular degeneration (ARMD) affects roughly 11 million people in the US and is the leading cause of visual impairment for older individuals. Its severe and rapid impact on vision requires vigilant prevention and screening practices, as well as a thorough understanding of diagnostic procedures and the optimal use of current and emerging therapies. This activity will provide an overview of the multiple subtypes of ARMD, including dry, intermediate, and wet ARMD, and geographic atrophy. It will explore existing and emerging therapies for ARMD subtypes, as well as their efficacy and safety profiles. In addition, testing strategies that can help determine the direction of ARMD management plans, as well as applications and programs for low-vision care, will be identified.
  • Disease management
  • Older adults
  • Wellness
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
$0.00
This activity will highlight the prevalence of UI; provide effective communication and shared decision-making techniques; and discuss how to assess, treat and provide follow-up care for UI including available resources to support care and management.

Pages